Colorectal cancer

Victor Moreno Aguado / Ramon Salazar Soler

PRINCIPAL INVESTIGATORS
  • Eric Jeffrey Duell
  • Mercedes Martinez Villacampa
  • Cristina Santos Vivas
  • Rebeca Sanz Pamplona
  • Gemma Soler González
CLINICAL RESEARCHERS
  • Doménico Fraccalvieri Fraccalvieri
  • Esther Kreisler Moreno
  • Ferran Losa Gaspà
  • Núria Mulet Margalef
  • Francisco Rodríguez Moranta
  • Jose Carlos Ruffinelli Rodríguez
  • Albert Sueiras Gil
POSTDOCTORAL RESEARCHERS
  • David Bars Cortina
  • Lourdes Criado Mesas
  • Gemma Ibañez Sanz
  • Marisa Martínez Muñoz
  • Mireia Obon Santacana
  • Elies Ramon Gurrea
  • Miguel Socolovsky Visiedo
PREDOCTORAL RESEARCHERS
  • Sandra Garcia Mulero
  • Ainhoa García Serrano
  • Joan Mas Lloret
  • Lois Riobo Mayo
  • Blanca Rius Sansalvador
SCIENTIFIC SUPPORT
  • Carmen Rosa Atencia Rojas
  • Daniel Azuara García
  • Anna Diez Villanueva
  • Elisabet Guino Domenech
  • Susana Lopez Ruiz
  • Ferran Moratalla Navarro
MANAGEMENT SUPPORT
  • Francesc Alarcon Moral
  • Paula Ximena Fernández Calotti
  • Claudia Lorena Latorre Gaviria
  • Olga Lopez Ciercoles
  • Silvia Múrcia Muñoz
  • Helena Peña Paris
  • Adelaida Piera Sancerni
  • Andrea Isabel Ruiz Valderrama
  • Jordi Vea Barbany
  • Catalina Cofré Muñoz
Cancer
Oncobell

Scientific production

72

PAPERS

Average IF: 9,738

18

LED PAPERS

Average IF: 6,311

17 PUBLICATIONS IN FIRST DECILE

50 PUBLICATIONS IN FIRST QUARTILE

56 PUBLICATIONS IN OPEN ACCESS

Selected publications:

  • Pinato DJ, Aguilar Company J, Ferrante D, Hanbury G, Bower M, Salazar R, Mirallas O, Sureda A, Plaja A, Cucurull M, Mesia R, Townsend S, Jackson A, Dalla Pria A, Newsom Davis T, Handford J, Sita Lumsden A, Apthorp E, Vincenzi B, Bertuzzi A, Brunet J, Lambertini M, Maluquer C, Pedrazzoli P, Biello F, Sinclair A, Bawany S, Khalique S, Rossi S, Rogers L, Murphy C, Belessiotis K, Carmona García MC, Sharkey R, García Illescas D, Rizzo G, Perachino M, Saoudi Gonzalez N, Doonga K, Fox L, Roldán E, Gaidano G, Ruiz Camps I, Bruna R, Patriarca A, Martinez Vila C, Cantini L, Zambelli A, Giusti R, Mazzoni F, Caliman E, Santoro A, Grosso F, Parisi A, Queirolo P, Aujayeb A, Rimassa L, Prat A, Tucci M, Libertini M, Grisanti S, Mukherjee U, Diamantis N, Fusco V, Generali D, Provenzano S, Gennari A, Tabernero J, Cortellini A, OnCovid study G. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. Lancet Oncol. 2022;23(7):865-875. doi:10.1016/S1470-2045(22)00273-X.
  • Jimenez Fonseca P, Salazar R, Valenti V, Msaouel P, Carmona Bayonas A. Is short-course radiotherapy and total neoadjuvant therapy the new standard of care in locally advanced rectal cancer? A sensitivity analysis of the RAPIDO clinical trial. Ann. Oncol. 2022;33(8):786-793. doi:10.1016/j.annonc.2022.04.010.
  • Olivera I, Sanz Pamplona R, Bolanos E, Rodriguez I, Etxeberria I, Cirella A, Egea J, Garasa S, Migueliz I, Eguren Santamaria I, Sanmamed MF, Glez Vaz J, Azpilikueta A, Alvarez M, Ochoa MC, Malacrida B, Propper D, de Andrea CE, Berraondo P, Balkwill FR, Teijeira A, Melero I. A therapeutically actionable pro-tumoral axis of cytokines involving interleukin-8, TNFa and IL-1B. Cancer Discov. 2022;12(9):2140-2157. doi:10.1158/2159-8290.CD-21-1115.
  • OnCovid Study G, Pinato DJ, Patel M, Scotti L, Colomba E, Dolly S, Loizidou A, Chester J, Mukherjee U, Zambelli A, Dalla Pria A, Aguilar Company J, Bower M, Salazar R, Bertuzzi A, Brunet J, Lambertini M, Tagliamento M, Pous A, Sita Lumsden A, Srikandarajah K, Colomba J, Pommeret F, Seguí E, Generali D, Grisanti S, Pedrazzoli P, Rizzo G, Libertini M, Moss C, Evans JS, Russell B, Harbeck N, Vincenzi B, Biello F, Bertulli R, Ottaviani D, Liñan R, Rossi S, Carmona García MC, Tondini C, Fox L, Baggi A, Fotia V, Parisi A, Porzio G, Queirolo P, Cruz CA, Saoudi Gonzalez N, Felip E, Roqué Lloveras A, Newsom Davis T, Sharkey R, Roldán E, Reyes R, Zoratto F, Earnshaw I, Ferrante D, Marco Hernández J, Ruiz Camps I, Gaidano G, Patriarca A, Bruna R, Sureda A, Martinez Vila C, Sanchez de Torre A, Berardi R, Giusti R, Mazzoni F, Guida A, Rimassa L, Chiudinelli L, Franchi M, Krengli M, Santoro A, Prat A, Tabernero J, Van Hemelrijck M, Diamantis N, Gennari A, Cortellini A. Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry. JAMA Oncol. 2022;8(1):114-122. doi:10.1001/jamaoncol.2021.6199.
  • Herpers B, Eppink B, James MI, Cortina C, Cañellas Socias A, Boj SF, Hernando Momblona X, Glodzik D, Roovers RC, van de Wetering M, Bartelink Clements C, Zondag van der Zande V, Mateos JG, Yan K, Salinaro L, Basmeleh A, Fatrai S, Maussang D, Lammerts van Bueren JJ, Chicote I, Serna G, Cabellos L, Ramírez L, Nuciforo P, Salazar R, Santos C, Villanueva A, Stephan Otto Attolini C, Sancho E, Palmer HG, Tabernero J, Stratton MR, de Kruif J, Logtenberg T, Clevers H, Price LS, Vries RGJ, Batlle E, Throsby M. Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors. Nat. Cancer. 2022;3(4):418-436. doi:10.1038/s43018-022-00359-0.

Research highlights

PROJECTS

6 Granted competitive projects
23 Ongoing competitive projects

6 Started clinical trials
28 Ongoing clinical trials

PUBLISHED WORKS

2 Clinical guidelines
2 Theses

NETWORKS

UNCAN.eu
PERSIST
AGAUR SGR GRC
CIBERESP

Selected projects

  • FIS22041. Understanding TIL composition and anti-tumor rEactivity in liver metastases from colorectal cancer patients (u-TIL-e ). Instituto de Salud Carlos III (ISCIII). Budget: 130680. 2023-2025. PI: Salazar Soler, Ramón / Losa Gaspà Ferran.
  • 18INT006. ACRCelerate: Colorectal Cancer Stratified Medicine Network. WORLD CANCER RESEARCH FUND INTERNATIONAL WCRFI. Budget: 78756,34. 2018-2023. PI: Salazar Soler, Ramón.
  • 21FIS026. ¿Cómo influye el microambiente inmune en el patrón de diseminación metastásica y supervivencia en. Instituto de Salud Carlos III (ISCIII). Budget: 123420. 2021-2023. PI: Santos Vivas, Cristina.
  • 18FIS005. Estudio de las interacciones microbioma-anfitrión para la prevención del cáncer colorrectal (Colonbiome). Instituto de Salud Carlos III (ISCIII). Budget: 202070. 2018-2022. PI: Moreno Aguado, Víctor; Pimenoff, Ville Nikolai.
  • 21ACL057. AN OPEN-LABEL STUDY OF THE EFFECT OF TESETAXEL ON THE QTC INTERVAL AND THE EFFECT OF FOOD, ITRACONAZOLE, AND RIFAMPIN ON TESETAXEL PHARMACOKINETICS IN PATIENTS WITH ADVANCED SOLID TUMORS. Budget: 178620. 2021- . PI: Mulet Margalef, Núria.
    .